36
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiology

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Wastewater-based epidemiology (WBE) demonstrates potential for COVID-19 community monitoring; however, data on the stability of SARS-CoV-2 RNA in wastewater are needed to interpret WBE results. The decay of RNA from SARS-CoV-2 and a potential surrogate, murine hepatitis virus (MHV), were investigated by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in untreated wastewater, autoclaved wastewater, and dechlorinated tap water stored at 4, 15, 25, and 37°C. Temperature, then matrix type, most greatly influenced SARS-CoV-2 RNA first-order decay rates ( k). The average T 90 (time required for 1 log 10 reduction) for RNA of SARS-CoV-2 ranged from 8.04 to 27.8 days in untreated wastewater, 5.71 to 43.2 days in autoclaved wastewater, and 9.40 to 58.6 days in tap water. The average T 90 for RNA of MHV at 4 to 37˚C ranged from 7.44 to 56.6 in untreated wastewater, 5.58 to 43.1 days in autoclaved wastewater, and 10.9 to 43.9 days in tap water. There was no statistically significant difference between RNA decay characteristics of SARS-CoV-2 and MHV were identified; thus, MHV is suggested as suitable persistence surrogate. Decay rate constants for all temperatures were comparable across all matrices for both viral RNAs, except in untreated wastewater for SARS-CoV-2, which showed less sensitivity to elevated temperatures. Therefore, SARS-CoV-2 RNA is likely to persist long enough in untreated wastewater to permit reliable detection.

          Highlights

          • Temperature most greatly influenced SARS-CoV-2 RNA first-order decay rates.

          • SARS-CoV-2 and MHV RNA decay characteristics were similar.

          • MHV is suggested as suitable persistence surrogate.

          • SARS-CoV-2 RNA is likely to persist long enough in wastewater to permit detection.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          Virological assessment of hospitalized patients with COVID-2019

          Coronavirus disease 2019 (COVID-19) is an acute infection of the respiratory tract that emerged in late 20191,2. Initial outbreaks in China involved 13.8% of cases with severe courses, and 6.1% of cases with critical courses3. This severe presentation may result from the virus using a virus receptor that is expressed predominantly in the lung2,4; the same receptor tropism is thought to have determined the pathogenicity-but also aided in the control-of severe acute respiratory syndrome (SARS) in 20035. However, there are reports of cases of COVID-19 in which the patient shows mild upper respiratory tract symptoms, which suggests the potential for pre- or oligosymptomatic transmission6-8. There is an urgent need for information on virus replication, immunity and infectivity in specific sites of the body. Here we report a detailed virological analysis of nine cases of COVID-19 that provides proof of active virus replication in tissues of the upper respiratory tract. Pharyngeal virus shedding was very high during the first week of symptoms, with a peak at 7.11 × 108 RNA copies per throat swab on day 4. Infectious virus was readily isolated from samples derived from the throat or lung, but not from stool samples-in spite of high concentrations of virus RNA. Blood and urine samples never yielded virus. Active replication in the throat was confirmed by the presence of viral replicative RNA intermediates in the throat samples. We consistently detected sequence-distinct virus populations in throat and lung samples from one patient, proving independent replication. The shedding of viral RNA from sputum outlasted the end of symptoms. Seroconversion occurred after 7 days in 50% of patients (and by day 14 in all patients), but was not followed by a rapid decline in viral load. COVID-19 can present as a mild illness of the upper respiratory tract. The confirmation of active virus replication in the upper respiratory tract has implications for the containment of COVID-19.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The species Severe acute respiratory syndrome-related coronavirus : classifying 2019-nCoV and naming it SARS-CoV-2

            The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic. The Coronaviridae Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the classification of viruses and taxon nomenclature of the family Coronaviridae, has assessed the placement of the human pathogen, tentatively named 2019-nCoV, within the Coronaviridae. Based on phylogeny, taxonomy and established practice, the CSG recognizes this virus as forming a sister clade to the prototype human and bat severe acute respiratory syndrome coronaviruses (SARS-CoVs) of the species Severe acute respiratory syndrome-related coronavirus, and designates it as SARS-CoV-2. In order to facilitate communication, the CSG proposes to use the following naming convention for individual isolates: SARS-CoV-2/host/location/isolate/date. While the full spectrum of clinical manifestations associated with SARS-CoV-2 infections in humans remains to be determined, the independent zoonotic transmission of SARS-CoV and SARS-CoV-2 highlights the need for studying viruses at the species level to complement research focused on individual pathogenic viruses of immediate significance. This will improve our understanding of virus–host interactions in an ever-changing environment and enhance our preparedness for future outbreaks.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community

              Infection with SARS-CoV-2, the etiologic agent of the ongoing COVID-19 pandemic, is accompanied by the shedding of the virus in stool. Therefore, the quantification of SARS-CoV-2 in wastewater affords the ability to monitor the prevalence of infections among the population via wastewater-based epidemiology (WBE). In the current work, SARS-CoV-2 RNA was concentrated from wastewater in a catchment in Australia and viral RNA copies were enumerated using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) resulting in two positive detections within a six day period from the same wastewater treatment plant (WWTP). The estimated RNA copy numbers observed in the wastewater were then used to estimate the number of infected individuals in the catchment via Monte Carlo simulation. Given the uncertainty and variation in the input parameters, the model estimated a median range of 171 to 1090 infected persons in the catchment, which is in reasonable agreement with clinical observations. This work highlights the viability of WBE for monitoring infectious diseases, such as COVID-19, in communities. The work also draws attention to the need for further methodological and molecular assay validation for enveloped viruses in wastewater.
                Bookmark

                Author and article information

                Contributors
                Journal
                Environ Res
                Environ. Res
                Environmental Research
                Published by Elsevier Inc.
                0013-9351
                1096-0953
                27 August 2020
                27 August 2020
                : 110092
                Affiliations
                [1 ]CSIRO Land and Water, Ecosciences Precinct, 41 Boggo Road, Dutton Park, QLD 4102, Australia
                [2 ]Department of Civil & Environmental Engineering & Earth Sciences, 156 Fitzpatrick Hall, University of Notre Dame, Notre Dame, IN 46656, USA
                [3 ]Interdisciplinary Center for River Basin Environment, University of Yamanashi, 4 - 3 -11 Takeda, Kofu, Yamanashi 400 -8511, Japan
                [4 ]Institute of Environmental Science and Research Ltd (ESR), Porirua, 5240, New Zealand
                [5 ]Centre for Immunology and Infection Control, Queensland University of Technology, 300 Herston Road, Herston, QLD 4006, Australia
                [6 ]United States Environmental Protection Agency, Office of Research and Development, 26W Martin Luther King Jr. Drive, Cincinnati, OH, 45268, USA
                [7 ]CSIRO Australian Centre for Disease Preparedness, Geelong, Vic 3220, Australia
                [8 ]Department of Environmental Health Sciences, Tulane University, 1440 Canal Street, New Orleans, LA, 70112, USA
                [9 ]CSIRO Land and Water, Lucas Heights, NSW 2234, Australia
                [10 ]Chulabhorn Research Institute, 54 Kampangpetch 6 Road, Laksi, Bangkok, 10210, Thailand
                [11 ]College of Marine Science, University of South Florida, 140 Seventh Avenue South, St. Petersburg, Florida 33701, USA
                [12 ]Queensland Alliance for Environmental Health Sciences (QAEHS), University of Queensland, 20 Cornwall Street, Woolloongabba, QLD 4102, Australia
                [13 ]Department of Health Sciences, University of York, York YO10 5DD, UK
                [14 ]Division of Environmental Engineering, Faculty of Engineering, Hokkaido University, North West 8, Kita-ku, Sapporo, Hokkaido 060-0032, Japan
                Author notes
                []Corresponding author. iling address: Ecosciences Precinct, 41 Boggo Road, Dutton Park 4102, Queensland, Australia. Tel.: +617 3833 5582; Warish.Ahmed@ 123456csiro.au
                Article
                S0013-9351(20)30989-0 110092
                10.1016/j.envres.2020.110092
                7451058
                32861728
                5ee1eb82-6fbc-449d-b47d-b0bdf2b8a756
                Crown Copyright © 2020 Published by Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 5 August 2020
                : 15 August 2020
                : 16 August 2020
                Categories
                Article

                General environmental science
                sars-cov-2,covid-19,murine hepatitis virus,enveloped virus,decay,temperature,wastewater

                Comments

                Comment on this article